Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
November 01 2016 - 1:25PM
Edgar (US Regulatory)
|
OMB
APPROVAL
|
|
OMB
Number:
|
3235-0167
|
|
Expires:
|
March
31, 2018
|
|
Estimated
average burden
|
|
hours
per response
|
1.50
|
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE
OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE
ACT OF 1934.
001-37426
Commission File Number
SUNOVION CNS DEVELOPMENT CANADA ULC
(Exact name
of registrant as specified in its charter)
828 Richmond Street West, Toronto, Ontario,
Canada M6J 1C9, (416) 703-2449
(Address, including
zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Shares, no par value
(Title of each
class of securities covered by this Form)
Not Applicable
(Titles of
all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es)
to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
x
|
|
Rule 12g-4(a)(2)
|
¨
|
|
Rule 12h-3(b)(1)(i)
|
x
|
|
Rule 12h-3(b)(1)(ii)
|
¨
|
|
Rule 15d-6
|
¨
|
|
Rule 15d-22(b)
|
¨
|
|
Approximate number of holders of record as of the
certification or notice date: One
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934 the registrant has caused this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
Dated:
November 1, 2016
|
Sunovion
CNS Development Canada ULC
|
|
|
|
By:
|
/s/
Gregory Bokar
|
|
Name:
|
Gregory Bokar
|
|
Title:
|
Director
|
Cynapsus Therapeutics Inc. (NASDAQ:CYNA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynapsus Therapeutics Inc. (NASDAQ:CYNA)
Historical Stock Chart
From Jul 2023 to Jul 2024